Static Chart Arrowhead Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 24/06/2025 BST			5-day change	1st Jan Change
15.96 ^USD	+2.90%		+2.97%	-15.11%

06-23	Arrowhead Pharmaceuticals Completes Enrollment in Shasta-3, Shasta-4, and Muir-3 Phase 3 Studies of Plozasiran	CI
06-18	Fat, not muscle: Drugmakers in race for next weight-loss breakthrough	RE

Duration

Period